- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.01. | FDA cancels adcomm in 'positive' sign for Exelixis' Cabometyx bid in neuroendocrine tumors: analyst | ||
| 10.01. | Matt McNally rejoins Publicis, leaving Omnicom for CEO role at agency's health unit | ||
| 10.01. | Fierce Pharma Asia-A $410M obesity debut; Another Roche ADC deal; Legend, BeiGene as buyout targets? | ||
| 10.01. | BD survey shows fear and discomfort delay gynecology visits | ||
| 09.01. | 10s for Tenpoint: Biotech preps for '26 market launch after phase 3 win for combo eye drop | ||
| 09.01. | Mendaera hires chief commercial officer for handheld medical robot launch | ||
| 09.01. | Sanofi scores with its subcutaneous version of Sarclisa as it tries to play catch up with J&J's Darzalex | ||
| 09.01. | Catalyst settles with Teva, staving off Firdapse generic until 2035 | ||
| 09.01. | Havas starts GLP-1 video series to show value of episodic online content | ||
| 09.01. | With BIOSECURE in limbo, should BeiGene or Legend sell itself in 2025? Analysts weigh in | ||
| 08.01. | Indian CDMO Anthem Biosciences files for $397M IPO amid expansion efforts | ||
| 08.01. | CDMO National Resilience plots 120 layoffs at former bluebird bio facility in Research Triangle Park | ||
| 08.01. | Launches from Novo, Lilly top Clarivate's annual 'Drugs to Watch' list | ||
| 08.01. | RSV vaccines from Pfizer, GSK take another hit with new FDA warning mandate | ||
| 08.01. | Swoop scoops up MyHealthTeam, buying patient social networks to boost pharma marketing | ||
| 08.01. | FleishmanHillard names BeiGene, HHS alum global managing director of health and life sciences | ||
| 07.01. | Letting go of Armgo: Biotech rebrands as RyCarma Therapeutics | ||
| 07.01. | New Woodstock CEO Nick Buschur plots growth strategy for Illinois blow-fill-seal CDMO | ||
| 07.01. | Verona touts 'exceptionally strong' launch of blockbuster hopeful COPD treatment Ohtuvayre | ||
| 07.01. | Wegovy and Zepbound tipped to fuel $20B boom in heart failure market | ||
| 07.01. | After tough year, Moderna CEO confronts challenges for RSV, COVID businesses in shareholder letter | ||
| 07.01. | Bausch + Lomb re-ups 'Faces of Glaucoma' campaign to raise awareness of the eye disease | ||
| 06.01. | Klick Health swoops in to acquire life sci market access agency Peregrine | ||
| 06.01. | FDA warning letter reveals quality control, data integrity issues at Viatris plant in India | ||
| 06.01. | FDA looks to clarify confirmatory trial mandate for accelerated approvals |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
